Reversible cerebral vasoconstriction syndrome: A review of pathogenesis, clinical presentation, and treatment.
Singhal AB.
Int J Stroke. 2023 Dec;18(10):1151-1160. doi: 10.1177/17474930231181250. Epub 2023 Jun 12.
Reversible cerebral vasoconstriction syndrome.
Ducros A.
Lancet Neurol. 2012 Oct;11(10):906-17. doi: 10.1016/S1474-4422(12)70135-7.
Aneurysmal Subarachnoid Hemorrhage: Review of the Pathophysiology and Management Strategies.
Osgood ML.
Curr Neurol Neurosci Rep. 2021 Jul 26;21(9):50. doi: 10.1007/s11910-021-01136-9.
"Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.
Lee KH, Lukovits T, Friedman JA.
Neurocrit Care. 2006;4(1):68-76. doi: 10.1385/NCC:4:1:068.
Cerebral vasospasm.
Baggott CD, Aagaard-Kienitz B.
Neurosurg Clin N Am. 2014 Jul;25(3):497-528. doi: 10.1016/j.nec.2014.04.008.
Clazosentan: First Approval.
Lee A.
Drugs. 2022 Apr;82(6):697-702. doi: 10.1007/s40265-022-01708-0.
The incidence of cerebral arterial vasospasm following aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis.
Donaldson L, Edington A, Vlok R, Astono I, Iredale T, Flower O, Ma A, Davidson K, Delaney A.
Neuroradiology. 2022 Dec;64(12):2381-2389. doi: 10.1007/s00234-022-03004-w. Epub 2022 Jul 7.
Vasospasm.
Bambakidis NC, Selman WR.
J Neurosurg. 2011 Apr;114(4):932-3; discussion 933-4. doi: 10.3171/2010.8.JNS101202. Epub 2010 Dec 17.
Cerebral Vasospasm: A Review.
Findlay JM, Nisar J, Darsaut T.
Can J Neurol Sci. 2016 Jan;43(1):15-32. doi: 10.1017/cjn.2015.288. Epub 2015 Sep 2.
Cerebral arterial spasm. A short review.
POTTER JM.
World Neurol. 1961 Jul;2:576-88.
